Security Snapshot

TRINITY BIOTECH PLC - @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB) Institutional Ownership

CUSIP: 896438306

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2024

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / @Class 'A' Ordinary Shares represented by American Depositary Shares
Symbol
TRIB on Nasdaq
Shares outstanding
18,697,629
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • TRIB - TRINITY BIOTECH PLC - @Class 'A' Ordinary Shares represented by American Depositary Shares is tracked under CUSIP 896438306.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 25 to 0 between Q4 2023 and Q1 2024.
  • Reported value moved from $2,583,427 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

896438306

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

TRIB full holder history TRINITY BIOTECH PLC SEC filings TRINITY BIOTECH PLC company facts TRINITY BIOTECH PLC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of TRINITY BIOTECH PLC - @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MiCo IVD Holdings, LLC 18% $31,252,824 69,450,720 MiCo IVD Holdings, LLC 17 Dec 2024
Novus Diagnostics Ltd. 6% 1,119,988 Novus Diagnostics Ltd. 23 Dec 2025

Institutional Holders of TRINITY BIOTECH PLC - @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$2,570,471 0
2023 Q4 6,017,301 $2,583,427 -$60,379 $0.43 25
2023 Q3 6,136,275 $4,492,942 -$57,991 $0.74 20
2023 Q2 6,203,359 $5,927,524 -$120,184 $0.95 20
2023 Q1 6,322,223 $5,960,890 -$246,043 $0.94 20
2022 Q4 6,575,585 $6,511,053 -$453,316 $0.99 20
2022 Q3 7,013,813 $7,494,454 -$301,117 $1.07 18
2022 Q2 7,293,307 $8,921,000 -$1,903,060 $1.22 17
2022 Q1 9,017,002 $9,558,000 +$3,817,525 $1.06 18
2021 Q4 5,387,370 $7,700,000 -$285,833 $1.43 17
2021 Q3 5,515,826 $11,909,000 -$396,530 $2.16 20
2021 Q2 5,663,570 $16,647,000 +$630,861 $2.94 26
2021 Q1 5,404,173 $20,322,000 -$2,001,163 $3.76 31
2020 Q4 5,935,793 $22,614,000 -$313,125 $3.81 22
2020 Q3 6,300,475 $12,723,000 -$2,024,499 $2.02 21
2020 Q2 7,280,574 $15,872,000 -$1,212,557 $2.18 24
2020 Q1 8,778,536 $9,657,000 -$1,744,161 $1.10 20
2019 Q4 10,421,414 $10,760,000 -$896,842 $1.03 23
2019 Q3 10,629,465 $12,858,000 -$2,017,166 $1.21 24
2019 Q2 11,817,237 $20,196,000 -$4,061,095 $1.65 30
2019 Q1 13,086,618 $37,292,000 -$263,164 $2.85 35
2018 Q4 13,207,308 $30,239,000 -$4,288,060 $2.29 35
2018 Q3 14,301,903 $57,202,000 -$1,180,790 $4.00 43
2018 Q2 14,578,989 $72,890,000 -$3,282,605 $5.00 42
2018 Q1 15,232,918 $78,447,079 +$1,820,197 $5.15 44
2017 Q4 14,924,359 $76,044,039 +$1,681,413 $5.10 42
2017 Q3 14,524,418 $81,482,846 -$2,328,511 $5.61 51
2017 Q2 14,929,650 $89,576,500 +$3,730,839 $6.00 52
2017 Q1 15,728,720 $93,738,571 -$476,505 $5.96 62
2016 Q4 15,753,386 $108,985,984 -$42,814,279 $6.92 67
2016 Q3 16,644,625 $220,116,744 -$2,676,769 $13.22 76
2016 Q2 16,872,606 $191,194,968 -$4,958,105 $11.34 79
2016 Q1 17,298,667 $201,618,632 +$108,770 $11.66 78
2015 Q4 17,279,232 $203,291,000 -$13,703,419 $11.76 80
2015 Q3 18,447,182 $211,037,011 -$4,320,965 $11.44 92
2015 Q2 17,535,838 $316,682,561 +$27,816,315 $18.06 91
2015 Q1 15,736,897 $301,929,686 +$11,583,352 $19.25 88
2014 Q4 15,193,426 $266,077,564 +$18,863,865 $17.51 91
2014 Q3 14,070,367 $256,965,851 +$1,941,076 $18.27 93
2014 Q2 13,789,099 $317,567,580 +$4,354,645 $23.03 92
2014 Q1 13,327,175 $322,994,594 +$21,079,034 $24.23 79
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .